| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 8960 |
| 1 | EVOLOCUMAB | 6709 |
| 2 | ETANERCEPT | 4229 |
| 3 | DENOSUMAB | 3675 |
| 4 | DUPILUMAB | 3253 |
| 5 | ERENUMAB-AOOE | 2980 |
| 6 | ALBUTEROL SULFATE | 2808 |
| 7 | ABATACEPT | 2322 |
| 8 | INSULIN LISPRO | 1769 |
| 9 | ADALIMUMAB | 1650 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CLASCOTERONE | 333 | 0.2347 |
| 1 | TRASTUZUMAB-ANNS | 346 | 0.2285 |
| 2 | DILUENT | 189 | 0.1830 |
| 3 | ADALIMUMAB-ATTO | 280 | 0.1739 |
| 4 | TUBERCULIN PURIFIED PROTEIN DERIVATIVE | 322 | 0.1707 |
| 5 | INFLIXIMAB-AXXQ | 143 | 0.1233 |
| 6 | INSULIN GLARGINE AND LIXISENATIDE | 402 | 0.1098 |
| 7 | EPOETIN ALFA | 1124 | 0.0951 |
| 8 | BEVACIZUMAB-AWWB | 437 | 0.0931 |
| 9 | CEFTAZIDIME, AVIBACTAM | 15 | 0.0888 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 11025 |
| 1 | PCSK9 Inhibitor [EPC] | 7071 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 5952 |
| 3 | Interleukin-23 Antagonist [EPC] | 3892 |
| 4 | RANK Ligand Inhibitor [EPC] | 3675 |
| 5 | Interleukin-4 Receptor alpha Antagonist [EPC] | 3253 |
| 6 | GLP-1 Receptor Agonist [EPC] | 2616 |
| 7 | Selective T Cell Costimulation Modulator [EPC] | 2322 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 1623 |
| 9 | Interleukin-17A Antagonist [EPC] | 1458 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 294 | 0.4273 |
| 1 | PCSK9 Inhibitor [EPC] | 7071 | 0.2746 |
| 2 | CXC Chemokine Receptor 4 Antagonist [EPC] | 2 | 0.2500 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 417 | 0.2010 |
| 4 | Skin Test Antigen [EPC] | 322 | 0.1707 |
| 5 | Endoglycosidase [EPC] | 95 | 0.0513 |
| 6 | Interleukin-17A Antagonist [EPC] | 1458 | 0.0391 |
| 7 | Selective T Cell Costimulation Blocker [EPC] | 177 | 0.0373 |
| 8 | Interleukin-23 Antagonist [EPC] | 3892 | 0.0372 |
| 9 | Lymphocyte Activation Gene-3 Blocker [EPC] | 19 | 0.0369 |